Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

S-nitrosoglutathione. Biochim Biophys Acta 2013 May;1830(5):3173-81

Date

02/19/2013

Pubmed ID

23416062

Pubmed Central ID

PMC3679660

DOI

10.1016/j.bbagen.2013.02.004

Scopus ID

2-s2.0-84875738207 (requires institutional sign-in at Scopus site)   264 Citations

Abstract

BACKGROUND: S-Nitrosoglutathione (GSNO) is the S-nitrosated derivative of glutathione and is thought to be a critical mediator of the down stream signaling effects of nitric oxide (NO). GSNO has also been implicated as a contributor to various disease states.

SCOPE OF REVIEW: This review focuses on the chemical nature of GSNO, its biological activities, the evidence that it is an endogenous mediator of NO action, and implications for therapeutic use.

MAJOR CONCLUSIONS: GSNO clearly exerts its cellular actions through both NO- and S-nitrosation-dependent mechanisms; however, the chemical and biological aspects of this compound should be placed in the context of S-nitrosation as a whole.

GENERAL SIGNIFICANCE: GSNO is a central intermediate in formation and degradation of cellular S-nitrosothiols with potential therapeutic applications; thus, it remains an important molecule of study. This article is part of a Special Issue entitled Cellular functions of glutathione.

Author List

Broniowska KA, Diers AR, Hogg N

Author

Neil Hogg PhD Associate Dean, Professor in the Biophysics department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Animals
Glutathione
Humans
Nitric Oxide
Nitrosation
S-Nitrosoglutathione
S-Nitrosothiols